AquaBounty Technologies, Inc. (AQB) is a land-based aquaculture company that previously pioneered genetically engineered Atlantic salmon. Following a series of asset sales, the company has transitioned into a wind-down phase rather than an operating growth story. This makes each quarterly earnings release less about revenue growth and more about cash runway, cost control, and the outcome of strategic alternatives. For investors, the third quarter 2026 report offers a checkpoint on how quickly the company is conserving capital while it works to sell its remaining Ohio Farm Project. Given the going-concern disclosures in recent filings, these results are closely watched for any sign of improved financial stability or progress on asset monetization. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AquaBounty announced its third quarter 2026 financial results on November 3, 2026, covering the period ended September 30, 2026. Because the company has exited active fish-rearing operations, product revenue has effectively ceased, and the income statement now reflects a much smaller operating base driven largely by general and administrative expenses and interest costs. In the most recent prior quarter, the second quarter of 2026, the company reported a loss of $0.26 per share, while the comparable year-ago period (third quarter 2025) reflected a net loss of approximately $1.4 million. The emphasis in the latest release remains on continued cost reduction, cash preservation, and progress toward realizing value from the Ohio Farm Project, which is held for sale and reported within discontinued operations.
Sentiment around AQB has been dominated by the company's restructuring rather than traditional operating fundamentals. With the stock trading as a low-priced, micro-cap name and a limited float, price moves around earnings can be amplified by thin liquidity. Following the release, investors are likely to interpret the results through the lens of cash runway and the viability of the strategic alternatives process, rather than revenue growth. Key risk factors include the company's ability to raise additional capital on acceptable terms, the timing and completion of any asset sale, and the potential for shareholder dilution from prior convertible-preferred and warrant issuances.
The most important factor ahead is the status of the Ohio Farm Project. A completed sale, or meaningful progress toward one, would represent the clearest catalyst for the company's balance sheet and could reshape investor expectations about remaining value. Conversely, extended delays or an inability to close a transaction would keep the going-concern risk firmly in view.
Cash management remains a close second. With a limited cash balance and ongoing administrative and interest expenses, the company's ability to fund operations until a strategic transaction is completed is a central question. Investors should monitor any additional capital raises, debt-for-equity conversions, or preferred-stock issuances, since each can affect both liquidity and the ownership structure for common shareholders.
Finally, watch for updates on Nasdaq listing compliance and any changes to the company's strategic direction. While management has signaled a wind-down, the completion of asset sales or a shift in the strategic alternatives process could materially alter the outlook. As always, these developments carry significant uncertainty and should be evaluated alongside the company's SEC filings rather than in isolation. From what I see, the AI Trend Prediction Engine can help flag potential shifts in similar micro-cap names during periods like this.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. The platform lets users scan thousands of stocks and ETFs with customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. By surfacing trade ideas, trending stocks, and breakout candidates more efficiently than manual screening, the AI Screener supports faster, more systematic research. Investors tracking situations like AquaBounty's can use it to identify comparable names, monitor momentum, and evaluate market opportunities at a glance. I often turn to this when reviewing wind-down scenarios to quickly compare liquidity metrics across peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for AQB turned positive on October 09, 2026. Looking at past instances where AQB's MACD turned positive, the stock continued to rise in 35 of 40 cases over the following month. The odds of a continued upward trend are 88%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AQB's RSI Oscillator exited the oversold zone, 37 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on AQB as a result. In 75 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
AQB moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for AQB crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.
Following a +15.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where AQB advanced for three days, in 155 of 207 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AQB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
AQB broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AQB entered a downward trend on October 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. AQB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.200) is normal, around the industry mean (2.288). P/E Ratio (-0.262) is within average values for comparable stocks, (4.947). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). AQB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.038). P/S Ratio (2.089) is also within normal values, averaging (2.353).
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AQB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a biotechnology company focused on improving productivity in commercial aquaculture
Industry AgriculturalCommoditiesMilling